BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38301924)

  • 1. Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patients.
    Masseran C; Perray L; Murat de Montai Q; Mathian A; Teboul A; Francès C; Arnaud L; Costedoat-Chalumeau N; Amoura Z; Courvoisier DS; Barbaud A; Chasset F
    J Am Acad Dermatol; 2024 Jun; 90(6):1210-1217. PubMed ID: 38301924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher specificity of the new EULAR/ACR 2019 criteria for diagnosing systemic lupus erythematosus in patients with biopsy-proven cutaneous lupus.
    Stec-Polak M; Matyja-Bednarczyk A; Wojas-Pelc A; Pastuszczak M
    Clin Exp Rheumatol; 2021; 39(5):955-960. PubMed ID: 32940207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum.
    Jin H; Huang T; Wu R; Zhao M; Wu H; Long H; Yin H; Liao J; Luo S; Liu Y; Zhang Q; Zhang P; Tan Y; Luo S; Huang X; Deng Y; Liao W; Duan L; Chen J; Zhou Y; Yin J; Qiu H; Yuan J; Wang Z; Li M; Wu X; Chen L; Cai L; Huang C; Li Q; Tang B; Yu B; Li X; Gao X; Hu Y; Ren X; Xue H; Wei Z; Chen J; Li F; Ling G; Luo H; Zhao H; Yang S; Cui Y; Lin Y; Yao X; Sun L; Guo Q; Fang H; Zeng K; Deng D; Zhang J; Li Y; Pu X; Liao X; Dang X; Huang D; Liang Y; Sun Q; Xie H; Zeng L; Huang C; Diao Q; Tao J; Yu J; Li Z; Xu H; Li H; Lai W; Liu X; Wu J; Li T; Lei T; Sun Q; Li Y; Zhang G; Huang X; Lu Q
    Lupus; 2020 Dec; 29(14):1854-1865. PubMed ID: 33028176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.
    Jarukitsopa S; Hoganson DD; Crowson CS; Sokumbi O; Davis MD; Michet CJ; Matteson EL; Maradit Kremers H; Chowdhary VR
    Arthritis Care Res (Hoboken); 2015 May; 67(6):817-28. PubMed ID: 25369985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential panorama of clinical features of lupus erythematosus patients with different onset ages: a cross-sectional multicenter study from China.
    Yu Y; Jin H; Zhou S; Zhao M; Wu H; Long H; Fu S; Wu R; Yin H; Liao J; Luo S; Liu Y; Zhang Q; Zhang P; Tan Y; Huang X; Li F; Lin G; Lu Q
    Clin Rheumatol; 2023 Sep; 42(9):2353-2367. PubMed ID: 37311918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatologic Manifestations, Histologic Features and Disease Progression among Cutaneous Lupus Erythematosus Subtypes: A Prospective Observational Study in Asians.
    Chanprapaph K; Tankunakorn J; Suchonwanit P; Rutnin S
    Dermatol Ther (Heidelb); 2021 Feb; 11(1):131-147. PubMed ID: 33280074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus.
    Tarazi M; Gaffney RG; Kushner CJ; Chakka S; Werth VP
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1404-1409. PubMed ID: 31058462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus.
    Wieczorek IT; Propert KJ; Okawa J; Werth VP
    JAMA Dermatol; 2014 Mar; 150(3):291-6. PubMed ID: 24477339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Risk of Autoimmune Diseases other than Systemic Lupus Erythematosus in Cutaneous Lupus Erythematosus-Alone Patients: A 10-Year Nationwide Cohort Study.
    Lin TL; Wu CY; Juan CK; Chang YT; Chen YJ
    Dermatology; 2022; 238(1):92-100. PubMed ID: 34062538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus.
    Jenks SA; Wei C; Bugrovsky R; Hill A; Wang X; Rossi FM; Cashman K; Woodruff MC; Aspey LD; Lim SS; Bao G; Drenkard C; Sanz I
    Ann Rheum Dis; 2021 Sep; 80(9):1190-1200. PubMed ID: 34083207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: a registry-based cohort study of 164 patients.
    Fredeau L; Courvoisier DS; Ait Mehdi R; Ingen-Housz-Oro S; Mahe E; Costedoat-Chalumeau N; Arnaud L; Francès C; Mathian A; Jachiet M; Amoura Z; Bouaziz JD; Chasset F;
    J Am Acad Dermatol; 2023 Mar; 88(3):551-559. PubMed ID: 36156304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
    Szepietowski JC; Nilganuwong S; Wozniacka A; Kuhn A; Nyberg F; van Vollenhoven RF; Bengtsson AA; Reich A; de Vries DE; van Hartingsveldt B; Robinson DW; Gordon R; Hsu B
    Arthritis Rheum; 2013 Oct; 65(10):2661-71. PubMed ID: 23896980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
    Grönhagen CM; Fored CM; Granath F; Nyberg F
    Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
    Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
    Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
    Zhou W; Wu H; Zhao M; Lu Q
    Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features.
    Wallace DJ; Pistiner M; Nessim S; Metzger AL; Klinenberg JR
    Semin Arthritis Rheum; 1992 Feb; 21(4):221-6. PubMed ID: 1570517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus.
    Flynn A; Gilhooley E; O'Shea F; Wynne B
    Clin Rheumatol; 2018 Mar; 37(3):817-818. PubMed ID: 29392510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.
    Hesselvig JH; Egeberg A; Kofoed K; Gislason G; Dreyer L
    Br J Dermatol; 2018 Nov; 179(5):1095-1101. PubMed ID: 29885269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1β and IL-17 in cutaneous lupus erythematous skin biopsies: could immunohistochemicals indicate a tendency towards systemic involvement?
    Lovato BH; Fogagnolo L; Souza EM; Silva LJBD; Velho PENF; Cintra ML; Teixeira F
    An Bras Dermatol; 2024; 99(1):66-71. PubMed ID: 37783618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
    Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
    Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.